Clinical Trial Update: Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating expanded natural killer cells after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Expanded Natural Killer Cells (expanded natural killer cells)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: RECRUITING